Jounce Therapeutics Investor Relations Material

Jounce Therapeutics Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for the treatment of cancer. The company leverages its expertise in immuno-oncology to discover and develop therapies that stimulate the immune system to recognize and attack tumors. Jounce's pipeline includes a range of biologic therapies that target various immune pathways, with the goal of improving patient outcomes in solid tumor cancers. The company collaborates with academic institutions and industry partners to advance its therapeutic candidates. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the Nasdaq.